If you concerned SAMR would be stopping approving, you’re completely wrong as SAMR just released two batch of SAMR approvals on 14 & 16 August 2018.
Vaccine accident only encourages Chinese mums buying more foreign brands, it’s in fact more beneficial to foreign infant formula brands as Chinese would be more cautious to buy domestic infant formulas, imo.
I am wondering how come you rate Bubs as a buy as they even haven’t lodged the SAMR application yet.
WHA Price at posting:
$1.40 Sentiment: Buy Disclosure: Held
